-
Symbol
-
YMAB
-
Investment type
-
Equity / Common stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
2.65M shares
-
Security Ownership
-
5.84%
Glazer Capital, LLC ownership in Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share (YMAB)
2025-08-15 - Glazer Capital, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.65M shares of Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share (YMAB).
This represents 5.84% percent ownership of the company.